Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) this morning offered an update on its scorpion venom-derived peptide research and development program, which consists of identifying, extracting and sequencing peptides and proteins isolated from Caribbean blue scorpion venom. Per the update, the program is progressing on schedule through the first of its three distinct phases. As previously noted, PreveCeutical has successfully separated several target scorpion venom-derived peptides and proteins using both one-dimensional gel electrophoresis (“1DE”) and two-dimensional gel electrophoresis (“2DE”). Next, the company’s research team aims to sequence the extracted peptides and proteins in order to determine their respective amino acid fingerprints, progressing toward the ultimate goal of enabling the creation of Nature Identical™ peptides.
To view the full press release, visit http://ibn.fm/PGR6V
Let us hear your thoughts: PreveCeutical Medical Inc. Message Board
About PreveCeutical Medical Inc.
PreveCeutical Medical Inc. is a health sciences company that develops innovative preventive therapies utilizing organic and nature identical products. PreveCeutical aims to be a leader in preventive health sciences and currently has five research and development programs, including: dual gene therapy for curative and prevention therapies for diabetes and obesity; a Sol-gel platform for nose to brain delivery of medical compounds including cannabinoids; Nature Identical™ peptides for treatment of various ailments; non-addictive analgesic peptides as a replacement to highly addictive analgesics such as morphine, fentanyl and oxycodone; and a therapeutic product for treating athletes who suffer from concussions (mild traumatic brain injury). PreveCeutical sells CELLB9®, an Immune System Booster. CELLB9 is an oral solution containing polarized and potentiated essential minerals extracted from a novel peptide obtained from Caribbean Blue Scorpion venom. For more information, visit the company’s website at www.PreveCeutical.com
QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.